Skip to main content
MGTX
NASDAQ Life Sciences

MeiraGTx Narrows Q3 Loss to $51.3M as Bota-Vec Filing Nears

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$9.49
Mkt Cap
$929.696M
52W Low
$6.62
52W High
$15.35
52W Position info
43% above low
Off High info
38% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MGTX sits 43% above its 52-week low of $6.62.

Summary

MeiraGTx posted a Q3 2026 net loss of $51.3 million, or $0.53 per share, versus a $50.5 million loss a year earlier, with R&D spending up to $39.3 million on the AAV2-hAQP1 and bota-vec programs. Cash and equivalents stood at $186.8 million at September 30, and management says that plus a $95.0 million upfront payment due from Hologen funds operations into the second half of 2028. The operational update is the real story: the bota-vec MAA dossier is complete and slated for EMA submission in December 2026, with the FDA BLA expected in Q1 2027 ahead of a late-2027 launch. The pivotal AQUAx2 12-month data readout for radiation-induced xerostomia remains on track for mid-2027. This follows the September 8-K adding Alan Sebulsky to the board and comes after a run of routine 10b5-1 insider sales filings in August and October.

At the time of this announcement, MGTX was trading at $9.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $929.7M. The 52-week trading range was $6.62 to $15.35. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MGTX - Latest Insights

MGTX
Aug 13, 2026, 8:23 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.89
Real-time Price: $9.49 info
Change: -$4.40 (-32%) info
Market Cap: $929.696M info
MGTX
Aug 13, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.29
Real-time Price: $9.49 info
Change: -$3.80 (-29%) info
Market Cap: $929.696M info
MGTX
Aug 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $13.29
Real-time Price: $9.49 info
Change: -$3.80 (-29%) info
Market Cap: $929.696M info
MGTX
Aug 11, 2026, 11:39 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.99
Real-time Price: $9.49 info
Change: -$3.50 (-27%) info
Market Cap: $929.696M info
MGTX
Jul 07, 2026, 7:42 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $14.42
Real-time Price: $9.49 info
Change: -$4.93 (-34%) info
Market Cap: $929.696M info